HC Wainwright upgraded Kyverna Therapeutics Inc. KYTX, citing three upcoming data sets through mid-2025. In its first quarter 2025 earnings released, the company highlighted: Enrollment is complete in the registrational Phase 2 KYV-101 trial for stiff person syndrome (SPS). The trial is on track for topline data and a biologics license application (BLA) filing is
The U.S. Food and Drug Administration (FDA) on Thursday issued a Complete Response Letter for Aldeyra Therapeutics, Inc.’s ALDX resubmission of the New Drug Application (NDA) of reproxalap, an investigational drug candidate, for dry eye disease. The FDA stated that the NDA “failed to demonstrate efficacy in adequate and well-controlled studies in treating ocular symptoms associated
BofA Securities analyst Lawson Winder discussed the performance of gold price last week and where it is headed. Gold prices have exceeded the analyst’s long-term target of $3,000 per ounce, with the analyst suggesting a potential rise to $3,500 if investment demand grows by 10%. China’s insurance sector could allocate up to 1% of its
JPMorgan Chase & Co.‘s JPM J.P. Morgan Asset Management penned a deal to enhance its Morgan Money offering through a strategic partnership with GLMX, a global money market trading platform. Morgan Money is a global trading platform that provides effective short-term investment management solutions tailored for institutional investors. With $313 billion in assets under management as
Analog Devices, Inc. ADI stock traded higher Wednesday after the company reported fiscal third-quarter results. The company’s revenue declined 25% year-on-year to $2.31 billion, beating the analyst consensus estimate of $2.27 billion. Adjusted EPS of $1.58 beat the analyst consensus estimate of $1.50. Analog Devices’ Industrial revenue declined by 37% year-on-year to $1.06 billion. Automotive revenue decreased 8% Y/year-on-year to $670.3 million. Communications revenue declined
GlobalFoundries Inc GFS reported a fiscal second-quarter 2024 revenue decline of 12% year-on-year to $1.63 billion, beating the analyst consensus estimate of $1.62 billion. The contract chipmaker’s adjusted EPS of 38 cents beat the analyst consensus estimate of 28 cents. Smartphone and mobile device revenue fell by around 3% from a year ago, while industrial IOT revenue declined